Literature DB >> 29635936

Chronorisk in cluster headache: A tool for individualised therapy?

Mads Barloese1,2, Bryan Haddock3, Nunu T Lund2, Anja Petersen2, Rigmor Jensen2.   

Abstract

BACKGROUND: The mechanisms behind the severe pain of cluster headache remain enigmatic. A distinguishing feature of the attacks is the striking rhythms with which they occur. We investigated whether statistical modelling can be used to describe 24-hour attack distributions and identify differences between subgroups.
METHODS: Common hours of attacks for 351 cluster headache patients were collected. Probability distributions of attacks throughout the day (chronorisk) was calculated. These 24-hour distributions were analysed with a multimodal Gaussian fit identifying periods of elevated attack risk and a spectral analysis identifying oscillations in risk.
RESULTS: The Gaussian model fit for the chronorisk distribution for all patients reporting diurnal rhythmicity (n = 286) had a goodness of fit R2 value of 0.97 and identified three times of increased risk peaking at 21:41, 02:02 and 06:23 hours. In subgroups, three to five modes of increased risk were found and goodness of fit values ranged from 0.85-0.99. Spectral analysis revealed multiple distinct oscillation frequencies in chronorisk in subgroups including a dominant circadian oscillation in episodic patients and an ultradian in chronic.
CONCLUSIONS: Chronorisk in cluster headache can be characterised as a sum of individual, timed events of increased risk, each having a Gaussian distribution. In episodic cluster headache, attacks follow a circadian rhythmicity whereas, in the chronic variant, ultradian oscillations are dominant reflecting a loss of association with sleep and perhaps explaining observed differences in the effects of specific treatments. The results demonstrate the ability to accurately model chronobiological patterns in a primary headache.

Entities:  

Keywords:  Cluster headache; autonomic nervous system; chronobiology; epidemiology; sleep

Mesh:

Year:  2018        PMID: 29635936     DOI: 10.1177/0333102418769955

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

Review 1.  CGRP-Targeted Therapy for Episodic and Chronic Cluster Headache.

Authors:  Shu-Ting Chen; Jr-Wei Wu
Journal:  Curr Pain Headache Rep       Date:  2022-07-26

2.  The economic and personal burden of cluster headache: a controlled cross-sectional study.

Authors:  Anja Sofie Petersen; Nunu Lund; Agneta Snoer; Rigmor Højland Jensen; Mads Barloese
Journal:  J Headache Pain       Date:  2022-05-24       Impact factor: 8.588

3.  Chronobiology and Sleep in Cluster Headache.

Authors:  Ilse F de Coo; Willebrordus P J van Oosterhout; Leopoldine A Wilbrink; Erik W van Zwet; Michel D Ferrari; Rolf Fronczek
Journal:  Headache       Date:  2019-05-31       Impact factor: 5.887

4.  Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.

Authors:  David W Dodick; Peter J Goadsby; Christian Lucas; Rigmor Jensen; Jennifer N Bardos; James M Martinez; Chunmei Zhou; Sheena K Aurora; Jyun Yan Yang; Robert R Conley; Tina Oakes
Journal:  Cephalalgia       Date:  2020-02-12       Impact factor: 6.292

5.  Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020.

Authors:  Henrik W Schytz; Faisal M Amin; Rigmor H Jensen; Louise Carlsen; Stine Maarbjerg; Nunu Lund; Karen Aegidius; Lise L Thomsen; Flemming W Bach; Dagmar Beier; Hanne Johansen; Jakob M Hansen; Helge Kasch; Signe B Munksgaard; Lars Poulsen; Per Schmidt Sørensen; Peter T Schmidt-Hansen; Vlasta V Cvetkovic; Messoud Ashina; Lars Bendtsen
Journal:  J Headache Pain       Date:  2021-04-08       Impact factor: 7.277

Review 6.  Current Understanding of the Chronobiology of Cluster Headache and the Role of Sleep in Its Management.

Authors:  Mads Barloese
Journal:  Nat Sci Sleep       Date:  2021-02-11

7.  Cluster headache in Asian populations: Similarities, disparities, and a narrative review of the mechanisms of the chronic subtype.

Authors:  Kuan-Po Peng; Tsubasa Takizawa; Mi Ji Lee
Journal:  Cephalalgia       Date:  2020-05-12       Impact factor: 6.292

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.